Who owns X4 Pharmaceuticals Inc?
- Ticker: XFOR
- CUSIP Number: 98420x103
Tip: Access positions for across all investors
Analyze quarterly positions in X4 Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of X4 Pharmaceuticals stock
Who bought or sold X4 Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors | 17M | $24M | 6% | Mar 2024 |
|
| NEA Management Company | 15M | $21M | 0% | Mar 2024 |
|
| BlackRock | 8.7M | $12M | 7% | Mar 2024 |
|
| Vanguard Group | 7.8M | $11M | -2% | Mar 2024 |
|
| OrbiMed Advisors | 7.1M | $9.9M | 0% | Mar 2024 |
|
| Soleus Capital Management | 4.6M | $6.4M | 100% | Mar 2024 |
|
| Adage Capital Partners GP | 4.3M | $5.9M | 0% | Mar 2024 |
|
| Sio Capital Management | 3.6M | $5.0M | 38% | Mar 2024 |
|
| Perceptive Advisors | 3.5M | $4.9M | 0% | Mar 2024 |
|
| Kingdon Capital Management | 3.5M | $4.8M | 0% | Mar 2024 |
|
| Axa | 3.1M | $4.3M | -2% | Mar 2024 |
|
| Geode Capital Management | 2.9M | $4.1M | 11% | Mar 2024 |
|
| Ensign Peak Advisors | 2.4M | $3.4M | 100% | Mar 2024 |
|
| Avidity Partners Management | 2.4M | $3.4M | 100% | Mar 2024 |
|
| Morgan Stanley | 1.4M | $2.0M | 482% | Mar 2024 |
|
| UBS O'Connor | 1.3M | $1.9M | 100% | Mar 2024 |
|
| Goldman Sachs Group | 1.1M | $1.5M | 1355% | Mar 2024 |
|
| Northern Trust | 1.1M | $1.5M | -1% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 915k | $1.3M | 67% | Mar 2024 |
|
| Citadel Advisors | 885k | $1.2M | -51% | Mar 2024 |
|
| Susquehanna International | 829k | $1.2M | 480% | Mar 2024 |
|
| Parkman Healthcare Partners | 805k | $1.1M | 1% | Mar 2024 |
|
| Point72 Asset Management | 650k | $904k | 0% | Mar 2024 |
|
| Propel Bio Management | 535k | $744k | 0% | Mar 2024 |
|
| Barclays | 449k | $623k | -15% | Mar 2024 |
|
| Nuveen Asset Management | 438k | $609k | 0% | Mar 2024 |
|
| Simplify Asset Management | 400k | $556k | 0% | Mar 2024 |
|
| Royce & Associates | 342k | $476k | -12% | Mar 2024 |
|
| Bank of New York Mellon | 336k | $467k | -3% | Mar 2024 |
|
| Charles Schwab Investment Management | 324k | $450k | 0% | Mar 2024 |
|
| GSA Capital Partners | 321k | $446k | -66% | Mar 2024 |
|
| Millennium Management | 259k | $360k | -84% | Mar 2024 |
|
| Rhumbline Advisers | 163k | $227k | 2% | Mar 2024 |
|
| UBS Group | 129k | $179k | 10437% | Mar 2024 |
|
| Citigroup | 127k | $169k | 621% | Mar 2024 |
|
| Bank of America Corporation | 103k | $143k | -52% | Mar 2024 |
|
| Stifel Financial | 86k | $120k | -5% | Mar 2024 |
|
| Amundi | 81k | $98k | 0% | Mar 2024 |
|
| Jane Street | 78k | $108k | -40% | Mar 2024 |
|
| Lighthouse Investment Partners | 70k | $98k | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 62k | $86k | -78% | Mar 2024 |
|
| American International | 61k | $51k | 0% | Dec 2023 |
|
| Dimensional Fund Advisors | 55k | $77k | 0% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 53k | $73k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 52k | $72k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 51k | $71k | -36% | Mar 2024 |
|
| Wolverine Trading | 48k | $67k | 17% | Mar 2024 |
|
| Walleye Trading Advisors | 48k | $66k | 61% | Mar 2024 |
|
| Alliancebernstein | 46k | $38k | 0% | Dec 2023 |
|
| Atlantic Trust | 45k | $64k | 0% | Mar 2024 |
|
| Vontobel Holding | 45k | $63k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 41k | $57k | 17% | Mar 2024 |
|
| Ing Investment Management | 41k | $56k | -18% | Mar 2024 |
|
| T. Rowe Price Associates | 39k | $55k | 47% | Mar 2024 |
|
| AQR Capital Management | 36k | $50k | -78% | Mar 2024 |
|
| Pnc Financial Services | 30k | $42k | 0% | Mar 2024 |
|
| Two Sigma Securities | 30k | $41k | 100% | Mar 2024 |
|
| Resources Investment Advisors | 29k | $40k | -6% | Mar 2024 |
|
| Commonwealth Equity Services | 25k | $35k | 0% | Mar 2024 |
|
| ProShare Advisors | 23k | $31k | 41% | Mar 2024 |
|
| Private Advisor | 22k | $30k | 0% | Mar 2024 |
|
| Group One Trading | 21k | $30k | -91% | Mar 2024 |
|
| SG Americas Securities | 21k | $29k | -56% | Mar 2024 |
|
| Cassady Schiller Wealth Management | 20k | $28k | 100% | Mar 2024 |
|
| Bleichroeder | 18k | $15k | 0% | Dec 2023 |
|
| Tower Research Capital | 16k | $23k | 58% | Mar 2024 |
|
| LexAurum Advisors | 16k | $13k | 0% | Dec 2023 |
|
| Victory Capital Management | 16k | $22k | -7% | Mar 2024 |
|
| Grimes & Company | 15k | $21k | 0% | Mar 2024 |
|
| Holistic Planning | 14k | $19k | 100% | Mar 2024 |
|
| Principal Financial Group | 14k | $19k | -18% | Mar 2024 |
|
| Total Clarity Wealth Management | 14k | $19k | 100% | Mar 2024 |
|
| Bp Wealth Management | 13k | $18k | 100% | Mar 2024 |
|
| Pathstone Holdings | 13k | $18k | 0% | Mar 2024 |
|
| California State Teachers Retirement System | 13k | $18k | -54% | Mar 2024 |
|
| LPL Financial | 12k | $16k | 10% | Mar 2024 |
|
| Legal & General Group | 11k | $16k | 0% | Mar 2024 |
|
| Summit Investment Advisors | 10k | $14k | 0% | Mar 2024 |
|
| 1620 Investment Advisors | 10k | $14k | 100% | Mar 2024 |
|
| Lazari Capital Management | 10k | $8.4k | 100% | Dec 2023 |
|
| Ronald Blue Trust | 8.5k | $12k | 0% | Mar 2024 |
|
| Amalgamated Bank | 4.2k | $6.0k | -71% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 4.0k | $5.6k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 2.9k | $0 | -93% | Mar 2024 |
|
| ICA Group Wealth Management | 2.8k | $3.8k | 7% | Mar 2024 |
|
| FMR | 2.5k | $3.5k | 61% | Mar 2024 |
|
| Hartland & Co | 2.1k | $1.8k | 0% | Dec 2023 |
|
| Raelipskie Partnership | 1.0k | $1.4k | 0% | Mar 2024 |
|
| Cubist Systematic Strategies | 469.00 | $652.003800 | -71% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 22.00 | $29.999200 | 100% | Mar 2024 |
|
| Frazier Financial Advisors | 10.00 | $14.000000 | 100% | Mar 2024 |
|
| CWM | 7.00 | $0 | 100% | Mar 2024 |
|
Who sold out of X4 Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Sep 2023 | 2.4M | $2.6M |
| Virtu Financial | Dec 2023 | 128k | $107k |
| Verition Fund Management | Sep 2023 | 88k | $96k |
| MetLife Investment Advisors | Sep 2023 | 65k | $71k |
| Squarepoint Ops | Dec 2023 | 65k | $54k |
| Bayesian Capital Management | Dec 2023 | 39k | $33k |
| Florida State Board of Administration | Dec 2023 | 32k | $27k |
| Hrt Financial | Dec 2023 | 17k | $14k |
| Mission Wealth Management | Dec 2023 | 10k | $8.4k |
| Metropolitan Life Insurance Company | Sep 2023 | 6.8k | $7.4k |
| Simplex Trading | Dec 2023 | 962.00 | $0 |